Table 5.
Cox multivariate regression analyses for the influence of preoperative serum prealbumin on overall survival in 246 ESCC patients with age ≤60 years without postoperative adjuvant radiotherapy or chemotherapy
| Variables | Hazard Ratio | P | 95% CI |
|---|---|---|---|
| Overall survival | |||
| Gender(f vs m) | 0.761 | 0.251 | 0.478–1.213 |
| Location(baseline, Proximal esophagus) | 0.082 | ||
| Mid esophagus | 0.450 | 0.025 | 0.224–0.907 |
| Distal esophagus | 0.490 | 0.056 | 0.236–1.018 |
| T stage | 2.008 | 0.002 | 1.301–3.101 |
| N stage | 2.717 | <0.001 | 1.790–4.127 |
| Differentiation(baseline, Well) | 0.180 | ||
| Moderately | 2.534 | 0.088 | 0.843–9.232 |
| Poorly | 3.092 | 0.063 | 0.913–8.534 |
| Prealbumin (baseline, high) | 0.035 | ||
| Low | 2.176 | 0.010 | 1.201–3.944 |
| Median | 1.25 | 0.246 | 0.858–1.821 |
| Albumin(low vs high) | 0.996 | 0.988 | 0.623–1.592 |
Abbreviations: ESCC, esophageal squamous cell carcinoma; CI, confidence interval.